Tivic Health Systems (NASDAQ:TIVC) Stock Price Down 3.3%

Shares of Tivic Health Systems, Inc. (NASDAQ:TIVCGet Rating) dropped 3.3% during mid-day trading on Monday . The company traded as low as $0.63 and last traded at $0.69. Approximately 1,700 shares changed hands during trading, a decline of 98% from the average daily volume of 73,844 shares. The stock had previously closed at $0.71.

Tivic Health Systems Stock Performance

The stock has a fifty day simple moving average of $1.04 and a 200-day simple moving average of $1.58.

Tivic Health Systems (NASDAQ:TIVCGet Rating) last announced its quarterly earnings data on Monday, November 14th. The company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.05. The company had revenue of $0.48 million during the quarter, compared to analysts’ expectations of $0.66 million. Tivic Health Systems had a negative return on equity of 120.72% and a negative net margin of 668.17%. On average, equities analysts forecast that Tivic Health Systems, Inc. will post -1.1 earnings per share for the current year.

Institutional Investors Weigh In On Tivic Health Systems

An institutional investor recently bought a new position in Tivic Health Systems stock. Renaissance Technologies LLC bought a new position in shares of Tivic Health Systems, Inc. (NASDAQ:TIVCGet Rating) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 122,234 shares of the company’s stock, valued at approximately $197,000. Renaissance Technologies LLC owned about 1.27% of Tivic Health Systems as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 0.22% of the company’s stock.

About Tivic Health Systems

(Get Rating)

Tivic Health Systems Inc operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S.

Read More

Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.